Toxicity in doberman pinchers with ventricular arrhythmias treated with amiodarone (1996-2005)

Journal of Veterinary Internal Medicine

Volumn 23, Issue 1, 2009, Pages 1-6

  Kraus, M S ^b   Thomason, J D ^a   Fallaw, T L ^a   Calvert, C A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Antiarrhythmic; Sudden death; Tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMICALLY INDUCED DISORDER; CONGESTIVE CARDIOMYOPATHY; DOG; DOG DISEASE; DOSE RESPONSE; FEMALE; HEART VENTRICLE TACHYCARDIA; LIVER DISEASE; MALE; RETROSPECTIVE STUDY;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHY, DILATED; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIVER DISEASES; MALE; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

CANIS FAMILIARIS;

EID: 61349133545     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0227.x     Document Type: Article

References (37)

1. Calvert CA, Chapman WH, Toal RL. Congestive cardiomyopathy in Doberman Pinscher dogs. J Am Vet Med Assoc 1982;181:598-602.
2. Calvert CA. Dilated cardiomyopathy in Doberman Pinschers. Comp Contin Educ Pract Vet 1986;6:417-430.
3. Calvert CA. Use of M-mode echocardiography in the diagnosis of cardiomyopathy in Doberman Pinschers. J Am Vet Med Assoc 1986;189:293-297.
4. Calvert CA, Hall G, Jacobs GJ, et al. Clinical and pathologic findings in Doberman Pinschers with occult cardiomyopathy that died suddenly or developed congestive heart failure: 54 cases (1984-1991). J Am Vet Med Assoc 1997;210:505-510.
5. Calvert CA, Jacobs GJ, Pickus CW, et al. Signalment, survival, and prognostic factors in Doberman Pinschers with end-stage cardiomyopathy. J Vet Intern Med 1998;11:323-331.
6. Smucker ML, Kaul S, Woodfield JA, et al. Naturally occurring cardiomyopathy in the Doberman Pinscher: A possible large animal model of human cardiomyopathy. J Am Coll Cardiol 1990;16:200-206.
7. James TN, Drake EH. Sudden death in Doberman Pinschers. Ann Intern Med 1968;68:821-829.
8. Calvert CA, Jacobs GJ, Pickus CW, et al. Results of ambulatory electrocardiography in overtly healthy Doberman Pinschers with echocardiographic abnormalities. J Am Vet Med Assoc 2000;217: 1328-1332.
9. Calvert CA, Jacobs GJ. Association between results ofambu-latory electrocardiography and development of cardiomyopathy during long-term follow-up of Doberman Pinschers. J Am Vet Med Assoc 2000;216:34-39.
10. Calvert CA, Jacobs CJ, Kraus M. Possible ventricular late potentials in Doberman Pinschers with occult cardiomyopathy. J Am Vet Med Assoc 1998;213:235-239.
11. Connolly SJ. Meta-analysis of antiarrhythmic drug trials. Am J Cardiol 1999;84:90R-93R.
12. Candinas R, Frielingsdorf J, Ha HR, et al. Myocardial am-iodarone concentrations after short- and long-term treatment in patients with end-stage heart failure. Eur J Clin Pharmacol 1998;53:331-336.
13. Coughlin SS, Neaton JD, Sengupta A, et al. Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the multiple risk factor intervention trial. Am J Epidemiol 1994;139:166-172.
14. Bhein S, Muller A, Gerwin R, et al. Comparative study on the proarrhythmic effects of some antiarrhythmic agents. Circulation 1993;87:617-621.
15. Mason J. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic study versus electrocardiographic monitoring investigators. N Engl J Med 1993;329:452-458.
16. Packer M, Bristow MR, Cohn JN, et al. The effect ofcarved-ilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:1349-1355.
17. Packer M, Coates AJS, Fowler MB, et al. Effect of carvedilol on survival in chronic severe heart failure. N Engl J Med 2001;233:1651-1658.
18. Poole-Wilson PA, Swedberg K, Cleland JGF, et al. For the Comet Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure. Results of the carvedilol or metoprolol European trial. Lancet 2003;362:7-13.
19. Podrid PJ. Amiodarone. Ann Intern Med 1995;122:689-694.
20. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999;100:2025-2034.
21. Piepoli M, Villani GQ, Ponikowski P, et al. Overview and metaanalysis of randomized trials of amiodarone in chronic heart failure. Int J Cardiol 1998;66:1-10.
22. Herre JM, Sauve MJ, Malone P, et al. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 1989;13:442-449.
23. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med 1995;333:77-82.
24. Castelli G, Ciaccheri M, Cecchi F, et al. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. G Ital Cardiol 1999;29:514-523.
25. Naccarelli GV, Wolbrette DL, Patel HM, et al. Amiodarone: Clinical trials. Curr Opin Cardiol 2000;15:64-72.
26. Hilleman DE, Barsman AL. Role of antiarrhythmic therapy in patients at risk for sudden death. Pharmacotherapy 2001;21:556-575.
27. Simon JB, Manley PN, Brien JF, et al. Amiodarone hepato-toxicity simulating alcoholic liver disease. N Engl J Med 1984;311:167-172.
28. Rigas B, Rosenfeld LE, Barwick KW, et al. Amiodarone he-patotoxicity: A clinical pathologic study of five patients. Arch Intern Med 1986;104:348-351.
29. Jacobs GJ, Calvert CA, Kraus MS. Hepatopathy in 4 dogs treated with amiodarone. J Vet Intern Med 2000;14:96-99.
30. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators. N Engl J Med 2000;392:913-920.
31. Vorperian VR, Havighurst TC, Miller S, et al. Adverse effects of low dose amiodarone: A meta-analysis. J Am Coll Card-iol 1997;30:791-798.
32. Calvert CA, Sammarco C, Pickus CV. Positive Coombs test results in two dogs administered oral amiodarone. J Am Vet Med Assoc 2000;216:1933-1936.
33. Boutitie F, Boissel JP, Connolly SJ, et al. Amiodarone interactions with beta-blockers. Analysis of the merged EMIAT and CAMIAT databases. The EMIAT and CAMIAT Investigators. Circulation 1999;99:2268-2275.
34. Nagele H, Bohlmann M, Eck U, et al. Combination therapy with carvedilol and amiodarone in patients with severe heart failure. Eur J Heart Fail 2000;2:71-79.
35. Marcus FL. Drug interactions with amiodarone. Am Heart J 1983;106:924-930.
36. DiMarco JP, Gersh BJ, Opie LH. Antiarrhythmic drugs and strategies. In: Opie LH, Gersh BJ, eds. Drugs for the Heart. Elsevier: Philadelphia, PA; 2006:218-274.
37. FuentesVL. Use of pimobendan in the management of heart failure. Vet Clin Small Anim 2004;34:1145-1155.